Search research articles
Contact Us
Filters
Showing results (291-300 of 311) with videos related to
Page
of 32
Sort By:
Bioengineered
|
May 2, 2022
Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis
Rong Fu, Shi-Jia Zu, Yan-Jun Liu, et al.
Neural Regeneration Research
|
December 15, 2020
Efficacy of short-term multidisciplinary intensive rehabilitation in patients with different Parkinson's disease motor subtypes: a prospective pilot study with 3-month follow-up
Ke-Ke Chen, Zhao-Hui Jin, Lei Gao, et al.
European Journal of Medicinal Chemistry
|
April 16, 2017
Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization
Fei Zhao, Le-Duo Zhang, Yu Hao, et al.
Plant Physiology
|
March 13, 2024
A nanopore-based cucumber genome assembly reveals structural variations at two QTLs controlling hypocotyl elongation
Bin Liu, Cheng-Cheng Shen, Shi-Wei Xia, et al.
Research (Washington, D.C.)
|
June 19, 2026
Regulation of Pore Evolution via Progressive Electroporation Enhanced Intracellular Molecule Transport
Xiao-Nan Tao, Xiao-Wei Xiang, Hao-Tian Liu, et al.
The EMBO Journal
|
July 28, 2025
Macrophages form dendrite-like pseudopods to enhance bacterial ingestion
Changyuan Fan, Xinyi Huang, Jie Mei, et al.
Cell Death & Disease
|
February 25, 2022
SUMOylation of PDPK1 Is required to maintain glycolysis-dependent CD4 T-cell homeostasis
Fei Sun, Fa-Xi Wang, He Zhu, et al.
Trials
|
June 16, 2023
Intermittent theta-burst stimulation combined with physical therapy as an optimal rehabilitation in Parkinson's disease: study protocol for a randomised, double-blind, controlled trial
Zhao-Hui Jin, Yi-Xuan Wang, De-Tao Meng, et al.
Acta Pharmacologica Sinica
|
April 14, 2021
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
Wen Li, Li-Ping Liao, Ning Song, et al.
Nature
|
December 5, 2024
Fetal hepatocytes protect the HSPC genome via fetuin-A
Xiao-Lin Guo, Yi-Ding Wang, Yan-Jun Liu, et al.
Page
of 32
Search research articles
Search
Showing results (291-300 of 311) with videos related to
Sort By:
Page
of 32
Bioengineered
|
May 2, 2022
Selective bromodomain and extra-terminal bromodomain inhibitor inactivates macrophages and hepatic stellate cells to inhibit liver inflammation and fibrosis
Rong Fu, Shi-Jia Zu, Yan-Jun Liu, et al.
Neural Regeneration Research
|
December 15, 2020
Efficacy of short-term multidisciplinary intensive rehabilitation in patients with different Parkinson's disease motor subtypes: a prospective pilot study with 3-month follow-up
Ke-Ke Chen, Zhao-Hui Jin, Lei Gao, et al.
European Journal of Medicinal Chemistry
|
April 16, 2017
Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization
Fei Zhao, Le-Duo Zhang, Yu Hao, et al.
Plant Physiology
|
March 13, 2024
A nanopore-based cucumber genome assembly reveals structural variations at two QTLs controlling hypocotyl elongation
Bin Liu, Cheng-Cheng Shen, Shi-Wei Xia, et al.
Research (Washington, D.C.)
|
June 19, 2026
Regulation of Pore Evolution via Progressive Electroporation Enhanced Intracellular Molecule Transport
Xiao-Nan Tao, Xiao-Wei Xiang, Hao-Tian Liu, et al.
The EMBO Journal
|
July 28, 2025
Macrophages form dendrite-like pseudopods to enhance bacterial ingestion
Changyuan Fan, Xinyi Huang, Jie Mei, et al.
Cell Death & Disease
|
February 25, 2022
SUMOylation of PDPK1 Is required to maintain glycolysis-dependent CD4 T-cell homeostasis
Fei Sun, Fa-Xi Wang, He Zhu, et al.
Trials
|
June 16, 2023
Intermittent theta-burst stimulation combined with physical therapy as an optimal rehabilitation in Parkinson's disease: study protocol for a randomised, double-blind, controlled trial
Zhao-Hui Jin, Yi-Xuan Wang, De-Tao Meng, et al.
Acta Pharmacologica Sinica
|
April 14, 2021
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
Wen Li, Li-Ping Liao, Ning Song, et al.
Nature
|
December 5, 2024
Fetal hepatocytes protect the HSPC genome via fetuin-A
Xiao-Lin Guo, Yi-Ding Wang, Yan-Jun Liu, et al.
Page
of 32